"Annual incidence rate of developing a primary malignant brain tumor httpshealth.usnews.comhealthnewspatientadvicearticlesharnessingtheimmunesystemtocombataggressivebraintumors is n population and the lifetime risk is . percent. In addition metastases from systemic cancer to the brain are  times more common than primary malignancy of the brain. Brain tumors can develop in both males and females and at any age though theyre more common in adults. The most common type of primary malignant brain tumors is malignant glioma. Brain tumors are diagnosed with clinical symptoms as well as advance imaging modalities of the brain such as computed tomography or magnetic resonance imaging. Conventional surgery is usually the first step to have tissue diagnosis and decrease the burden of tumor. However its not a cure for malignant brain tumors and is usually followed by other types of adjuvant treatments such as radiation andor chemotherapy. Not all brain tumors are amenable to conventional surgery for multiple reasons  such as location in deep parts of the brain with limited surgical access or being adjacent to critical structures. In addition in some conditions increased risk of morbidity is seen after surgery like in recurrent tumors with prior radiation or surgery. These patients especially in the recurrent setting have limited treatment options httpshealth.usnews.comhealthnewspatientadviceslideshowsinnovationsincancertherapy. Focused highdose radiation like stereotactic radiosurgery is useful in brain metastasis and could be used as initial treatment. However radiosurgery is not useful for malignant primary brain tumors like gliomas and even in metastasis it does have variable degree of failure based upon the size of tumor and prescribed radiation dose. Patients who are suffering from deep seated or recurrent primary brain tumors as well as those with brain metastases who failed radiation httpshealth.usnews.comhealthnewspatientadvicearticlesradiationevolvingchoicesincancertreatment have limited options and may benefit from alternative treatments like laser ablation. Laser ablation is a minimally invasive treatment modality for brain tumors that uses laser technology to increase the temperature of tumor and subsequently kill tumor cells. It also might have a role in enhancement of chemotherapy httpshealth.usnews.comhealthnewspatientadvicearticleseatingonchemotipstoovercometasteandweightchallenges and radiation therapy effects by disruption of repair mechanisms in tumor cells and increase the permeability of blood vessels of brain. Unlike conventional surgery it doesnt need extensive surgical exposure. Actually it works through a small stab incision in the skin and a small hole in the skull. Laser probe will be inserted using intraoperative navigation and controlled firing of the laser will cause an increase in the temperature of tumor and eventually destruction of tumor cells. Although this technology has been around for decades new technical advancements like specific MRthermometric scans during surgery have an almost realtime measurement of brain temperature and control of the extension of treatment field which allows the robotic probe driver to change direction and the depth of laser probe during surgery to have complete coverage of the tumor. Plus a completely newly designed laser probe with a builtin cooling system prevents excessive temperature of the probe during surgery which has made a resurgence of this treatment modality for intracranial applications in recent years. Since five years ago when the NeuroBlate System was approved by the Food and Drug Administration hundreds of patients with brain tumors httpshealth.usnews.combesthospitalsrankingsneurologyandneurosurgery who used to be considered inoperable underwent this procedure successfully with promising outcomes. Its especially crucial for patients with brain tumors in difficulttoaccess locations as well as for those who have experienced failure of prior radiation treatment. Being a relatively new procedure NeuroBlate doesnt yet qualify as a standard treatment for brain tumors. However initial results have been promising and further studies are on the way.  For patients with a malignant brain tumor having more quality time with family and friends httpshealth.usnews.comhealthnewspatientadvicearticlesrobitussinforbraincancerpartii is sometimes all that they can wish for. NeuroBlate might be a ray of hope in their gray sky."